Organic Sales Growth Performance: Procter & Gamble reported a 3% organic sales growth in the second quarter, driven by strong volume contributions (2 points) with mix adding 1 point. Sales growth was broad-based across categories, with Family Care up double-digits and other categories reflecting mid to low single-digit growth rates. The guidance for fiscal 2025 maintains an organic sales growth range of 3% to 5%, reflecting an expectation for stronger results in the second half of the year.
Earnings Per Share (EPS) Guidance: Core EPS grew 2% year-over-year to $1.88, with a currency-neutral increase of 3%. The full-year EPS guidance remains between $6.91 to $7.05, translating to a growth of 5% to 7% compared to fiscal 2024’s core EPS of $6.59. However, there are negative pressures including increased foreign exchange headwinds estimated at a reduction of $0.12 per share for fiscal 2025.
Challenges from External Factors: The company cited ongoing challenges from input costs, currency volatility, and geopolitical dynamics which are affecting consumer behavior and market growth. The projected commodities cost headwind for the year is about $200 million after tax, alongside the significant foreign exchange impacts above.